Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHAINARONG LIMVARAPUSS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1053341784
CMS profile
47890
Location
VALLEJO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$4,635.30

233 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,512.57 226
Education $122.73 7

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $311.10 10
GENZYME CORPORATION $265.54 14
PFIZER INC. $246.28 15
Lilly USA, LLC $222.84 13
Janssen Biotech, Inc. $220.76 13
Astellas Pharma US Inc $212.70 12
Pharmacyclics LLC, An AbbVie Company $192.01 8
Eisai Inc. $179.12 11
Merck Sharp & Dohme Corporation $161.47 10
Seagen Inc. $147.60 9
Kite Pharma, Inc. $143.78 6
Amgen Inc. $143.68 6
JAZZ PHARMACEUTICALS INC. $143.51 2
Regeneron Healthcare Solutions, Inc. $128.71 2
E.R. Squibb & Sons, L.L.C. $119.41 9
GlaxoSmithKline, LLC. $111.83 8
Novartis Pharmaceuticals Corporation $111.70 7
US Oncology Corporate, Inc. $108.02 1
Genentech USA, Inc. $98.77 5
Celgene Corporation $95.12 5
Incyte Corporation $90.93 5
Takeda Pharmaceuticals U.S.A., Inc. $84.35 3
Ipsen Biopharmaceuticals, Inc $74.24 4
Acrotech Biopharma LLC $68.60 4
Clovis Oncology, Inc. $66.59 3
Rigel Pharmaceuticals, Inc. $63.10 3
Epizyme, Inc., $62.40 3
ARRAY BIOPHARMA INC $56.17 3
SANOFI-AVENTIS U.S. LLC $53.43 3
Boehringer Ingelheim Pharmaceuticals, Inc. $52.93 3
Myriad Genetic Laboratories, Inc. $51.92 2
EMD Serono, Inc. $51.39 3
Myovant Sciences Inc. $49.49 2
Acceleron Pharma, Inc. $47.75 2
BeiGene USA, Inc. $37.73 2
Organon LLC $36.39 3
Roche Diagnostics Corporation $34.99 2
Daiichi Sankyo Inc. $33.45 2
AMAG Pharmaceuticals, Inc. $32.20 2
Gilead Sciences, Inc. $27.05 2
Alexion Pharmaceuticals, Inc. $24.33 1
TerSera Therapeutics LLC $23.68 1
Heron Therapeutics, Inc. $20.11 1
Taiho Oncology, Inc. $19.15 1
Deciphera Pharmaceuticals Inc. $17.99 1
Mylan Institutional Inc. $17.06 1
MorphoSys, US Inc. $16.77 1
Octapharma USA, Inc. $16.54 1
Servier Pharmaceuticals LLC $15.09 1
AbbVie Inc. $14.14 1
Global Blood Therapeutics, Inc. $11.39 1

Page 3 of 5; records 101–150 of 233 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHAINARONG LIMVARAPUSS

NPI 1053341784 · CMS profile ID 47890

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

VALLEJO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 233 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1053341784?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHAINARONG LIMVARAPUSS, NPI 1053341784, CMS profile ID 47890. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 233 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1053341784?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). CHAINARONG LIMVARAPUSS, NPI 1053341784, CMS profile ID 47890. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 233 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1053341784?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
CHAINARONG LIMVARAPUSS, NPI 1053341784, CMS profile ID 47890, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 233 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1053341784?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

233 matching records · $4,635.30 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 233 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 233.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Myriad Genetic Laboratories, Inc. $25.9608/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834574595 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.0008/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763596252 CMS
GENZYME CORPORATION $25.4607/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843497359 CMS
Epizyme, Inc., $19.0407/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832341453 CMS
Astellas Pharma US Inc $16.9307/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821422985 CMS
GENZYME CORPORATION $20.9707/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843497373 CMS
Lilly USA, LLC $4.6607/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819004785 CMS
Seagen Inc. $18.9307/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832149879 CMS
Lilly USA, LLC $20.3207/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818999833 CMS
Roche Diagnostics Corporation $19.2907/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844260865 CMS
AstraZeneca Pharmaceuticals LP $23.6107/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829482259 CMS
Incyte Corporation $12.3807/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835529143 CMS
EMD Serono, Inc. $18.4907/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849198303 CMS
GENZYME CORPORATION $22.5507/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843497357 CMS
Pharmacyclics LLC, An AbbVie Company $14.5807/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781012419 CMS
Merck Sharp & Dohme Corporation $13.8107/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848473419 CMS
AMAG Pharmaceuticals, Inc. $15.5907/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 847687823 CMS
Eisai Inc. $4.9907/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 817950007 CMS
Janssen Biotech, Inc. $15.7206/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788973063 CMS
Celgene Corporation $17.4906/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783694967 CMS
GENZYME CORPORATION $12.7806/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843497355 CMS
Lilly USA, LLC $4.5806/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819008835 CMS
Pharmacyclics LLC, An AbbVie Company $18.7506/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781012417 CMS
Janssen Biotech, Inc. $22.5206/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788973065 CMS
Janssen Biotech, Inc. $22.9206/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788973075 CMS
Servier Pharmaceuticals LLC $15.0906/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852923949 CMS
Astellas Pharma US Inc $14.7506/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821422973 CMS
Astellas Pharma US Inc $9.7006/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821422979 CMS
Deciphera Pharmaceuticals Inc. $17.9906/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826796257 CMS
Eisai Inc. $16.1006/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 817949991 CMS
Kite Pharma, Inc. $30.0006/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844417137 CMS
Astellas Pharma US Inc $12.5806/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821422967 CMS
Ipsen Biopharmaceuticals, Inc $16.7606/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841908785 CMS
PFIZER INC. $3.5006/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832703345 CMS
Alexion Pharmaceuticals, Inc. $24.3306/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783110357 CMS
E.R. Squibb & Sons, L.L.C. $18.7506/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783503883 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.7406/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820050291 CMS
Merck Sharp & Dohme Corporation $6.0006/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848492537 CMS
Novartis Pharmaceuticals Corporation $12.1806/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813029143 CMS
GENZYME CORPORATION $27.9906/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843497341 CMS
Gilead Sciences, Inc. $11.9206/01/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845875763 CMS
Rigel Pharmaceuticals, Inc. $22.9306/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854324513 CMS
Astellas Pharma US Inc $11.6205/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821422961 CMS
GENZYME CORPORATION $4.3705/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843497339 CMS
GlaxoSmithKline, LLC. $4.3605/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801643391 CMS
GlaxoSmithKline, LLC. $12.3205/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802817897 CMS
Celgene Corporation $24.0005/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783694965 CMS
Ipsen Biopharmaceuticals, Inc $17.2505/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841906035 CMS
Merck Sharp & Dohme Corporation $22.9805/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848528655 CMS
Merck Sharp & Dohme Corporation $23.9105/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848706789 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $15,465.16 244
PY2020 $7,138.60 71
PY2021 $4,635.30 233
PY2022 $14,191.47 276
PY2023 $8,228.90 234
PY2024 $5,772.17 191
PY2025 $4,852.26 202

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $5,100.00 3
PY2022 Principal investigator $16,500.00 3
PY2021 Principal investigator $14,677.00 11
PY2020 Principal investigator $6,120.00 4
PY2019 Principal investigator $2,760.00 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 MorphoSys AG $1,500.00 12/01/2023 Non-covered Recipient Entity
Solano Hematology Oncology
realMIND: A Multicenter, Observational Study to Characterize the Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in US Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma With a Focus on Racial and Ethnic Minority Patients No dispute reported 06/30/2026 1060334937
Principal investigator 1 MorphoSys AG $600.00 06/14/2023 Non-covered Recipient Entity
Solano Hematology Oncology
realMIND: A Multicenter, Observational Study to Characterize the Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in US Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma With a Focus on Racial and Ethnic Minority Patients No dispute reported 06/30/2026 1060334935
Principal investigator 1 PFIZER INC. $3,000.00 01/05/2023 Non-covered Recipient Entity
Solano Hematology Oncology
POLARIS PALBOCICLIB IN HORMONE RECEPTOR POSITIVE ADVANCED BREAST CANCER A PROSPECTIVE MULTICENTER NONINTERVENTIONAL STUDY No dispute reported 06/30/2026 1046547031